See Credit Details Below
Overview
Why You Should Attend:
This Studio Briefing will guide counsel on the recent reporting requirements for parties involved in healthcare M&A deals. The panel will examine the 2023 Merger Guidelines, the new Hart-Scott-Rodino (HSR) premerger filing rules and litigation against private equity (PE)-backed medical platforms. The panel will also profile the latest state legislative activity regarding the scrutiny of healthcare M&A deals and will discuss how the new laws are changing the playing field. The panel will address the considerations those involved in healthcare deals need to keep in mind and will offer best practices for navigating the new requirements.
Healthcare M&A deals are under increasing scrutiny. A number of states have enacted or are considering new laws related to pre-closing review of healthcare M&A deals. 2024 was important year, as California's new requirements went into effect and Indiana passed a comprehensive law. Meanwhile, seven states failed to pass similar legislation that would augment existing laws. Pennsylvania most recently reviewed whether to pass its own version of these laws, but did not pass a bill prior to the end of the legislative session.
In addition to heightened state scrutiny of healthcare deals, federal regulators have increased their scrutiny of healthcare M&A deals by proposing legislation that would scrutinize private equity investments. The FTC and DOJ have also focused on roll-up strategies and platforms that have significant market concentration and recently updated their Merger Guidelines and HSR rules to enhance the reporting process.
Counsel need to prepare for the impact of the new requirements when considering the timelines for transactions as well as the uncertainty created by the additional review and oversight.
What You Will Learn:
After completing this program, viewers will be able to:
- Examine case studies and scenarios incorporating recent updates to reporting requirements, merger guidelines and legislative developments
- Review recent reporting requirements for parties involved in healthcare M&A deals
- Examine the FTC’s new merger guidelines, the new Hart-Scott-Rodino (HSR) premerger filing rules and litigation against private equity (PE)-backed medical platforms
- Profile the latest state legislative activity regarding the scrutiny of healthcare M&A deals and discuss how the new laws are changing the playing field
- Special Coverage of the Following States: California, New Mexico, Indiana, Pennsylvania
- Address the considerations those involved in healthcare deals need to keep in mind and offer best practices for navigating the new requirements with a proactive antitrust approach
Who Should Attend:
Counsel engaged in healthcare M&A deals should find this program to be helpful.
PLI’s Studio Briefings are on-demand video CLE programs that feature an intimate and engaging round table discussion format with legal and industry experts addressing a range of topics. Visit our landing page for our library of PLI Studio Briefings.